Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 15, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 15, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 178,938 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 11,887 · Balance 178,938 F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 23, 2026 00:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 11,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-029338 · form4.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,938 F1 · shares: The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 22:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-026460 · form4.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,051 F1 · shares: The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 21:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 20,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-033631 · form4.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,376 F1 · shares: The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 01:11 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 17,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-035723 · form4.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,835 F1 · shares: The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 22:16 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014359 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,794 F1 · shares: The acquisition of 7,060 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 21:13 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,022 | $0.00 Strike: $15.95 | $0.00 |
DisclosureSEC source: 0001567619-22-008816 · doc1.xml · derivative · entry 2 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,022 shares Expires 2022-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for 33 1/3% of the shares became exercisable on 07/22/2016, 07/22/2017 and 07/22/2018, respectively. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 21:13 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 6,022 | $15.95 | $96,050.90 |
DisclosureSEC source: 0001567619-22-008816 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 22:59 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 5,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-013931 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,712 F1 · shares: The acquisition of 5,738 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 5,738 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/21/2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:53 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,726 | $0.00 Strike: $14.64 | $0.00 |
DisclosureSEC source: 0001567619-21-007649 · doc1.xml · derivative · entry 3 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,726 shares Expires 2021-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-fourth of the shares became exercisable on 8/12/2015, 8/12/2016, 8/12/2017 and 8/12/2018, respectively. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:53 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 3,621 | $23.15 | $83,826.15 |
DisclosureSEC source: 0001567619-21-007649 · doc1.xml · nonDerivative · entry 2 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,974 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:53 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 5,726 | $14.64 | $83,828.64 |
DisclosureSEC source: 0001567619-21-007649 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 22:58 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 15,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-013363 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,869 F1 · shares: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021. Read SEC document |
| July 17, 2019 Filed Jul 20, 2019 01:13 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015025 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,546 F1 · shares: The acquisition of 7,057 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,057 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/17/2020. Read SEC document |
| July 18, 2018 Filed Jul 21, 2018 01:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 6,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-033077 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,489 F1 · shares: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 20:26 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,650 | $0.00 Strike: $10.68 | $0.00 |
DisclosureSEC source: 0001140361-18-029787 · doc1.xml · derivative · entry 3 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,650 shares Expires 2019-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-fourth of the shares became exercisable on 8/7/2013, 8/7/2014, 8/7/2015 and 8/7/2016, respectively. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 20:26 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 3,171 | $22.40 | $71,030.40 |
DisclosureSEC source: 0001140361-18-029787 · doc1.xml · nonDerivative · entry 2 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,182 Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 20:26 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 6,650 | $10.68 | $71,022.00 |
DisclosureSEC source: 0001140361-18-029787 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 18:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001140361-17-043659 · doc1.xml · derivative · entry 3 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-third of the shares became exercisable on August 3, 2012, August 3, 2013 and August 3, 2014, respectively. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 18:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 10,873 | $17.42 | $189,407.66 |
DisclosureSEC source: 0001140361-17-043659 · doc1.xml · nonDerivative · entry 2 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,703 Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 18:48 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $13.53 | $189,420.00 |
DisclosureSEC source: 0001140361-17-043659 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 19:17 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-029092 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,576 F1 · shares: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018. Read SEC document |
| July 21, 2017 Filed Jul 22, 2017 01:46 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | PurchaseCommon Stock | 5,000 | $15.72 | $78,600.00 |
DisclosureSEC source: 0001140361-17-028417 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,600 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.71 to $15.72, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. Read SEC document |
| June 19, 2017 Filed Jun 22, 2017 01:42 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $15.75 | $0.00 |
DisclosureSEC source: 0001140361-17-025746 · doc1.xml · derivative · entry 3 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2017-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for 33 1/3% of the total number of shares each became exercisable on 8/3/2011, 8/3/2012 and 8/3/2013. Read SEC document |
| June 19, 2017 Filed Jun 22, 2017 01:42 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 13,544 | $16.28 | $220,496.32 |
DisclosureSEC source: 0001140361-17-025746 · doc1.xml · nonDerivative · entry 2 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,600 Read SEC document |
| June 19, 2017 Filed Jun 22, 2017 01:42 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $15.75 | $220,500.00 |
DisclosureSEC source: 0001140361-17-025746 · doc1.xml · nonDerivative · entry 1 DONNELLY HOWARD W · CIK 0001212978 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.